论文部分内容阅读
目的:对不同治疗方法在小儿急性肺炎治疗中的临床疗效进行探讨,为临床合理用药提供依据。方法:选取2013年6月~2014年5我院收治的小儿急性肺炎120例作为研究对象;随机分为甲、乙、丙三组,各40例;其中,甲组患儿予以抗生素头孢曲松钠静脉滴注治疗,乙组患儿予以头孢曲松钠与利巴韦林静脉联用滴注治疗,丙组患儿予以头孢曲松钠与炎琥宁联用静脉滴注治疗;观察、分析三组治疗方法的临床疗效。结果:治疗7d后:(1)三组患儿的治疗总有效率为65%、85%、97.5%,丙组优于乙组优于甲组,(P<0.05);(2)在退热时间、咳嗽消失时间、肺部体征恢复时间方面,丙组快于乙组快于甲组,(P<0.05);(3)三种治疗方法皆未发现明显药物毒性反应或不良反应,(P<0.05)。结论:在临床治疗小儿急性肺炎的过程中,仅运用抗生素予以治疗,其效果略差,利巴韦林联合头孢曲松钠治疗,其疗效确切,而炎琥宁与头孢曲松钠联用效果较优,值得临床推广。
Objective: To discuss the clinical curative effect of different treatment methods in the treatment of pediatric acute pneumonia, and to provide the basis for clinical rational drug use. Methods: A total of 120 children with acute pneumonia admitted to our hospital from June 2013 to 2014 were enrolled in this study. They were randomly divided into three groups (A, B and C), 40 cases each. Group A patients were given antibiotics ceftriaxone Sodium intravenous infusion therapy, B group of patients given ceftriaxone sodium and ribavirin intravenous drip treatment, C group of patients given ceftriaxone sodium and Yan Hu Ning intravenous infusion treatment; observation and analysis Three groups of treatment of clinical efficacy. Results: After 7 days of treatment, (1) the total effective rate of the three groups of children was 65%, 85% and 97.5%, respectively, which was better than group B in group C (P <0.05); (2) (3) All the three treatment methods showed no obvious toxicity or side effects, ((2) the time of cough disappeared and the time of recovery of lung signs were faster in group C than in group B (P <0.05) P <0.05). Conclusion: In the clinical treatment of children with acute pneumonia in the process, the use of antibiotics to treat, the effect is slightly worse, ribavirin combined with ceftriaxone sodium treatment, the exact effect, and Yan Hu Ning and ceftriaxone sodium combined effect Better, worthy of clinical promotion.